Takeda New Frontier Science (NFS) aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients’ lives.
Author: globalcorporateventuring
Takeda shakes up external innovation
Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), while Ilan Zipkin and Gordon Wong join.
J&J sets up four centres
Johnson & Johnson is setting up four innovation centres in California and Boston in the US, in the UK and in Shanghai, China.
Cisco identifies triple helix model for innovation
Anne Lange, director of the global public sector at Cisco’s internet business solutions group, says: “The knowledge-based economy puts a
stronger emphasis on the value of knowledge capital and access to primary sources of innovation. It forces academics, politicians and businesses to shape new collaborations and decrypt, together, these complex ecosystems.”
Symposium round-up
This article features some of the notable points and soundbites from the 39 keynotes and panel discussions at the Global Corporate Venturing Symposium 2012. For the transcripts and slides (where available) of the presentations, please click on the links.
Gaule’s Question Time: Dominique Mégret, Swisscom
Gaule: Give a brief description of the purpose of your venture, when it was formed and how the process occurs in your organisation. Mégret: Swisscom Ventures was formed in 2006 to strengthen Swisscom’s innovation ecosystem. We already had an outpost in Silicon Valley [California, US] back then, but we felt we needed to develop our… Continue reading Gaule’s Question Time: Dominique Mégret, Swisscom
The power of partnership
US-based healthcare companies Merck and Cleveland Clinic outline their strategies in these edited highlights from Global Corporate Venturing’s symposium last month in London.
Profile: Johnson & Johnson Development Corporation
Johnson & Johnson’s unbroken history of taking minority equity stakes in third-party entrepreneurs marks it as one of the oldest and most consistent investors in corporate venturing, writes James Mawson
Some healthy opportunities
Healthcare might be undergoing some macro-challenges as governments worry about how they will pay for people’s health in their old age, but it is also throwing up opportunities for non-traditional providers to enter the wellness sector. Consumer goods companies, such as Nestlé, Coca-Cola and Unilever, are looking at how their products might be used to… Continue reading Some healthy opportunities
Healthcare 2012: Well-being defines a growing sector
Healthcare corporations are filling a void left by retreating venture capital firms in their sector.
The explosion explained
The counter-cyclical activity of the present corporate venturing boom reverses the pattern of the past 40 years, where corporate venturing units started just when valuations were highest and before they crashed often leading to losses. James Mawson explains why.
Symposium 2012: SVB and Synchrony
Gerald Brady from SVB swaps war stories with Adam Caper from Synchrony.
Symposium 2012: Innogy and Topell
Crispin Leick from Innogy Ventures and Jules Kortenhorst from Topell provide a War Stories discussion.
Symposium 2012: IBM and Profitero
Panel Discussion: WAR STORIES, moderated by Gerald Brady from Silicon Valley Bank